DNMT3B and hepatocellular carcinoma: Following TERT inhibition with siRNA, a substantial decrease in both DNMT3B gene and protein levels indicated that TERT promoted DNMT3B expression in HCC, moreover, increased TERT and DNMT3B expression was associated with shorter survival times of HCC patients [54].